Brown-Forman Corporation

Q4 FY25Beverages

Brown-Forman Corporation Q4 FY25 Results — Earnings Call Analysis

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹26

Market cap₹12.0K Cr

P/E15.2

Published30 May 2026

What the Q4 FY25 call signalled

2 of 3 strong

RevenueRank 5

MarginRank 2

CapexYes

Not discussed on this call: fundraise, order book.

The short version

- **Organic Sales Guidance:** Expect a low to mid-single-digit decline in organic sales in the back half of fiscal 2026, with full year guided to a low single-digit decline. - **Emerging Markets:** Solid double-digit growth continues, though moderating from 25% in Q1 to 12% year-to-date; emerging markets like Mexico and Brazil remain key growth drivers. - **U.S. - Brown-Forman expects organic operating income to decline in the low single-digit range for fiscal 2026.

From Brown-Forman Corporation's Q4 FY25 earnings-call transcript · updated 30 May 2026.

Revenue & Sales Performance

Rank 5

**Organic Sales Guidance:** Expect a low to mid-single-digit decline in organic sales in the back half of fiscal 2026, with full year guided to a low single-digit decline.
**Emerging Markets:** Solid double-digit growth continues, though moderating from 25% in Q1 to 12% year-to-date; emerging markets like Mexico and Brazil remain key growth drivers.
**U.S. Market:** Flat organic net sales in the first half, with expectations of normalization as distributor transitions complete and launches like Jack Daniel’s Tennessee Blackberry mature.
**Distributor Impact:** Distributor changes have narrowed the shipment-to-depletion gap, aiding sales execution.
**Trade Down/TDS:** Total distilled spirits trends remain rational but continue to face cyclical headwinds like consumer trade down and cost inflation.
**Long-Term:** Management expresses confidence in returning to growth by navigating current volatility, focusing on strategic innovation and portfolio strength.

Profitability & Margins

Brown-Forman expects organic operating income to decline in the low single-digit range for fiscal 2026.
Reported operating income decreased 9% in H1 FY26; organic operating income decreased 4%.
Diluted EPS decreased 13% to $0.83 per share in H1 FY26.
Full-year outlook for organic operating income decline in low single digits is reaffirmed amid ongoing sector headwinds.
Top line organic sales expected to decline low to mid-single digits in the back half of fiscal 2026.
Gross margin expected to expand due to absence of Korbel and transition services agreement costs, offset by price/mix headwinds and inflation.
Capital expenditures reduced, improving cash flow and free cash flow generation.
Dividend increased 2%, marking 42 consecutive years of increases, underscoring confidence in long-term earnings power.
Overall, short-term profitability is expected to be pressured, but management is confident in long-term growth prospects.

See what Brown-Forman Corporation said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Yes

Brown-Forman has reduced its full-year fiscal 2026 capital expenditure outlook to a range of $110 million to $120 million, down from the prior range of $125 million to $135 million.
The reduction reflects completion of several projects and expansions, providing sufficient distilling, warehousing, and bottling capacities to support future demand.
The company is focusing on reducing finished goods inventory, which will lower working capital needs and improve cash flow.
Capital allocation balances ongoing investments in organic growth and acquisitions with shareholder returns (dividends, share repurchases).
As of October 31, 2025, $99 million in shares have been repurchased out of an authorized $400 million program.
The company remains committed to fully investing behind the business but is strategically moderating CapEx given current operating conditions.

Fundraising & Capital Structure

There is no mention of any current or planned new fundraising through debt or equity in the provided transcript.
The company discusses capital allocation focusing on sustainable long-term value creation via organic investments, acquisitions, dividends, and share repurchases.
The Board has authorized a share repurchase program of up to $400 million, with $99 million repurchased as of October 31, 2025.
Capital expenditures have been reduced due to project completions and working capital improvements, improving cash flow and free cash flow.
The firm highlights strong cash flow generation and balance sheet strength, suggesting no immediate need for raising funds through new debt or equity.

See what Brown-Forman Corporation said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The document does not explicitly provide detailed data on the current or expected order book or pending orders. However, relevant points touching on shipments, inventory, and distribution include: - Shipments in the first half of fiscal 2026 were slightly ahead of depletions due to loading new distributors and product launches like Jack Daniel’s Tennessee Blackberry. - Expectation that the gap between shipments and depletions will narrow in the full year, though shipments may remain slightly ahead due to ongoing launches. - Inventory reduction efforts are ongoing, producing at lower levels to reduce finished goods inventory and working capital needs. - New distribution partnerships and transitions in the U.S. are contributing positively; ordering patterns expected to normalize in the second half. - No specific quantitative order book or pending order figures were disclosed.

How does Brown-Forman Corporation rank vs peers in Beverages?

Pro feature

ThisBrown-Forman Corporation

Rev 5Mar 2

See where Brown-Forman Corporation sits in BeveragesSee which companies these are, and every other name in the sector.Open rankings

Others in Beverages this season

Ambev S.A. (Q4 FY25)
Ambev S.A. Q4 FY25 quarterly results analysis. Year-to-date top line grew 4%, EBITDA up 8%, EPS up 7%, indicating profitable growth momentum (Page 10). Market C
Anheuser-Busch InBev SA/NV (Q4 FY25)
Anheuser-Busch InBev SA/NV Q4 FY25 quarterly results analysis. Long-term fundamentals of the business remain strong despite short-term volume pressures due to c

Compare:vs PepsiCo, Inc.vs Anheuser-Busch InBev SA/NV vs Monster Beverage Corporation

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Brown-Forman Corporation Q4 FY25 results?

What is Brown-Forman Corporation share price analysis?

Brown-Forman Corporation currently shows a neutral. The stock trades at a P/E of 15.2 with a market cap of $11,991. Investors should review the full earnings analysis for detailed insights.

Is Brown-Forman Corporation planning capital expenditure?

- Brown-Forman has reduced its full-year fiscal 2026 capital expenditure outlook to a range of $110 million to $120 million, down from the prior range of $125 million to $135 million.

Keep Brown-Forman Corporation on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.